Reconsidering the Importance of Long‐Term Low‐Level Aluminum Exposure in Renal Failure Patients
暂无分享,去创建一个
[1] J. Andía,et al. Adynamic Bone and Chronic Renal Failure: An Overview , 2000 .
[2] C. Jb,et al. [Evolution of the aluminum concentration in the final dialysis solution: Multicenter study in Spanish dialysis centers]. , 2000 .
[3] P. E. Newman,et al. Alzheimer's disease revisited. , 2000, Medical hypotheses.
[4] A. Kumar,et al. Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[5] Burke,et al. Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] J. Cannata Andía. Adynamic bone and chronic renal failure: an overview. , 2000, The American journal of the medical sciences.
[7] M. Tsunoda,et al. Altered dopamine turnover in murine hypothalamus after low-dose continuous oral administration of aluminum. , 1999, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[8] Raghubir P. Sharma,et al. Modulation of tumor necrosis factor α expression in mouse brain after exposure to aluminum in drinking water , 1999, Archives of Toxicology.
[9] J. Cannata-Andía. Renal osteodystrophy in Iberoamerica. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] C. Exley. A molecular mechanism of aluminium-induced Alzheimer's disease? , 1999, Journal of inorganic biochemistry.
[11] B. Garrett,et al. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] M. Rogers,et al. A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. , 1999, Age and ageing.
[13] J. Cannata-Andía,et al. Hypokinetic azotemic osteodystrophy. , 1998, Kidney international.
[14] W. Forbes,et al. Is exposure to aluminum a risk factor for the development of Alzheimer disease?--Yes. , 1998, Archives of neurology.
[15] V. Hachinski. Aluminum exposure and risk of Alzheimer disease. , 1998, Archives of Neurology.
[16] V. Felipo,et al. Chronic Exposure to Aluminum Impairs Neuronal Glutamate‐Nitric Oxide‐Cyclic GMP Pathway , 1998, Journal of neurochemistry.
[17] J. Hdez-Jaras,et al. Accidental Aluminum Intoxication in Patients Undergoing Acetate-Free Biofiltration , 1998, Nephron.
[18] D. Munoz. Is exposure to aluminum a risk factor for the development of Alzheimer disease?--No. , 1998, Archives of neurology.
[19] A. Canteros,et al. Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] V. Jorgetti,et al. Epidemiology of renal osteodystrophy in Iberoamerica. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] P. Massari. Disorders of bone and mineral metabolism after renal transplantation. , 1997, Kidney international.
[22] W. Forbes,et al. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? , 1996, Journal of toxicology and environmental health.
[23] E. Bonucci,et al. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] A. Canteros,et al. Staining of bone aluminium: comparison between aluminon and solochrome azurine and their correlation with bone aluminium content. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] M. D. de Broe,et al. Adequacy of dialysis: trace elements in dialysis fluids. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] M. Monier‐Faugere,et al. Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] M. Arduino,et al. Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. , 1995, Kidney international.
[28] D Hernández,et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.
[29] Y. Pei,et al. Risk factors for renal osteodystrophy: A multivariant analysis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] C. Caramelo,et al. Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication. , 1995, Kidney international.
[31] A. Torres,et al. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] B. Lacour,et al. Gastrointestinal absorption of aluminum in rats using 26Al and accelerator mass spectrometry. , 1993, Clinical nephrology.
[33] Y. Pei,et al. The spectrum of bone disease in end-stage renal failure--an evolving disorder. , 1993, Kidney international.
[34] S. Hummel,et al. Diagnostic and therapeutic approaches to aluminium overload in dialysed patients--representative study by questionnaire in West German dialysis units in 1989-1990. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] J. Achard,et al. Use of alkaline calcium salts as phosphate binder in uremic patients. , 1992, Kidney international. Supplement.
[36] V. Lorenzo,et al. Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] J. Cannata,et al. The parathyroid gland and aluminum overload: an overview. , 1988, Contributions to Nephrology.
[38] R. Giordano,et al. Bone aluminum intoxication: an unpreventable sequel of parathyroidectomy? , 1988, Nephron.
[39] H. Malluche,et al. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. , 1986, Kidney international.
[40] J. Delmez,et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. , 1986, The New England journal of medicine.
[41] Rs Rs. Evolución de los parámetros de conducción nerviosa en pacientes bajo tratamiento con DPCA. Comparación con pacientes en hemodiálisis. Evolución de parámetros de conducción nerviosa. , 1986 .
[42] J. Jb. Absorción gastrointestinal de aluminio. Análisis de factores implicados , 1986 .
[43] E. Slatopolsky,et al. Suppression of parathyroid hormone secretion by aluminum. , 1983, Kidney international.
[44] J. Harrelson,et al. Osteomalacia after parathyroidectomy in patients with uremia. , 1982, Annals of internal medicine.
[45] T. Feest,et al. FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY An Epidemiological Survey , 1979, The Lancet.
[46] W. D. Kaehny,et al. The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.